Literature DB >> 11820894

Diastereoselective synthesis of protected syn 1,3-diols: preparation of the C16-C24 portion of Dolabelides.

Laurence Grimaud1, Romain de Mesmay, Joëlle Prunet.   

Abstract

We have designed a new method to make synthons encompassing a protected syn 1,3-diol motif and an aldehyde alpha to the 1,3-dioxane ring. An additional stereocenter was also created, potentially leading to stereochemically defined 1,2,4-triols. This method was successfully applied to the synthesis of the C16-C24 portion of Dolabelides.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11820894     DOI: 10.1021/ol017122w

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  6 in total

1.  Stereoselective synthesis of the C(1)-C(13) segment of dolabelide B.

Authors:  Gary E Keck; Mark D McLaws
Journal:  Tetrahedron Lett       Date:  2005-07-18       Impact factor: 2.415

2.  Total synthesis of dolabelide D.

Authors:  Peter K Park; Steven J O'Malley; Darby R Schmidt; James L Leighton
Journal:  J Am Chem Soc       Date:  2006-03-08       Impact factor: 15.419

3.  Total synthesis of dolabelide C: a phosphate-mediated approach.

Authors:  Paul R Hanson; Rambabu Chegondi; John Nguyen; Christopher D Thomas; Joshua D Waetzig; Alan Whitehead
Journal:  J Org Chem       Date:  2011-04-29       Impact factor: 4.354

4.  E- and Z-trisubstituted macrocyclic alkenes for natural product synthesis and skeletal editing.

Authors:  Yucheng Mu; Felix W W Hartrampf; Elsie C Yu; Katherine E Lounsbury; Richard R Schrock; Filippo Romiti; Amir H Hoveyda
Journal:  Nat Chem       Date:  2022-05-16       Impact factor: 24.274

5.  A multifaceted phosphate tether: application to the C1-C14 subunit of dolabelides A-D.

Authors:  Joshua D Waetzig; Paul R Hanson
Journal:  Org Lett       Date:  2007-12-07       Impact factor: 6.005

6.  A multifaceted phosphate tether: application to the C15-C30 subunit of dolabelides A-D.

Authors:  Alan Whitehead; Joshua D Waetzig; Christopher D Thomas; Paul R Hanson
Journal:  Org Lett       Date:  2008-03-07       Impact factor: 6.005

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.